{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T13:14:12Z","timestamp":1788786852248,"version":"build-2803163510"},"reference-count":120,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100022299","name":"Shahid Beheshti University of Medical Sciences School of Medicine","doi-asserted-by":"publisher","award":["43005119"],"award-info":[{"award-number":["43005119"]}],"id":[{"id":"10.13039\/501100022299","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005851","name":"Shahid Beheshti University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005851","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003968","name":"Iran National Science Foundation","doi-asserted-by":"publisher","award":["4001322"],"award-info":[{"award-number":["4001322"]}],"id":[{"id":"10.13039\/501100003968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.neuropharm.2024.110057","type":"journal-article","created":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T08:37:39Z","timestamp":1719909459000},"page":"110057","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Reversal of electrophysiological and behavioral deficits mediated by 5-HT7 receptor upregulation following LP-211 treatment in an autistic-like rat model induced by prenatal valproic acid exposure"],"prefix":"10.1016","volume":"257","author":[{"given":"Mona","family":"Rahdar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shima","family":"Davoudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samaneh","family":"Dehghan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2045-6171","authenticated-orcid":false,"given":"Mohammad","family":"Javan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narges","family":"Hosseinmardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gila","family":"Behzadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahyar","family":"Janahmadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.neuropharm.2024.110057_bib1","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/wps.21078","article-title":"Candidate biomarkers in psychiatric disorders: state of the field","volume":"22","author":"Abi-Dargham","year":"2023","journal-title":"World Psychiatr."},{"issue":"9","key":"10.1016\/j.neuropharm.2024.110057_bib2","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1093\/ijnp\/pyy043","article-title":"Motor impairments correlate with social deficits and restricted neuronal loss in an environmental model of autism","volume":"21","author":"Al Sagheer","year":"2018","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"17","key":"10.1016\/j.neuropharm.2024.110057_bib3","first-page":"1","article-title":"Oxotremorine treatment reduces repetitive behaviors in BTBR T+ tf\/J mice","volume":"6","author":"Amodeo","year":"2014","journal-title":"Front. Synaptic Neurosci."},{"issue":"8","key":"10.1016\/j.neuropharm.2024.110057_bib4","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1038\/sj.mp.4001099","article-title":"Serotonin transporter promoter variants in autism: functional effects and relationship to platelet hyperserotonemia","volume":"7","author":"Anderson","year":"2002","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2024.110057_bib5","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1038\/s41380-020-00868-3","article-title":"Serotonin transporter availability in adults with autism \u2014 a positron emission tomography study","author":"Andersson","year":"2021","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2024.110057_bib6","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/j.1749-6632.1998.tb10191.x","article-title":"Regulation of membrane excitability in the central nervous system by serotonin receptor subtypes","volume":"861","author":"Andrade","year":"1998","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"2","key":"10.1016\/j.neuropharm.2024.110057_bib7","first-page":"672","article-title":"5-Hydroxytryptamine (7) receptor activation decreases slow afterhyperpolarization amplitude in CA3 hippocampal pyramidal cells","volume":"294","author":"Bacon","year":"2000","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"10","key":"10.1016\/j.neuropharm.2024.110057_bib8","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.tins.2021.08.005","article-title":"Hippocampal contributions to social and cognitive deficits in autism spectrum disorder","volume":"44","author":"Banker","year":"2021","journal-title":"Trends Neurosci."},{"issue":"3","key":"10.1016\/j.neuropharm.2024.110057_bib9","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.pneurobio.2008.09.007","article-title":"Hyperpolarization activated cyclic-nucleotide gated (HCN) channels in developing neuronal networks","volume":"86","author":"Bender","year":"2008","journal-title":"Prog. Neurobiol."},{"issue":"2","key":"10.1016\/j.neuropharm.2024.110057_bib10","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1046\/j.1460-9568.2002.02072.x","article-title":"Differential modulation of Ih by 5-HT receptors in mouse CA1 hippocampal neurons","volume":"16","author":"Bickmeyer","year":"2002","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2024.110057_bib11","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1152\/physrev.00029.2008","article-title":"Hyperpolarization-activated cation channels: from genes to function","volume":"89","author":"Biel","year":"2009","journal-title":"Physiol. Rev."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110057_bib12","doi-asserted-by":"crossref","first-page":"240 LP","DOI":"10.1124\/jpet.302.1.240","article-title":"Reconsideration of 5-hydroxytryptamine (5-ht)7 receptor distribution using [3H]5Carboxamidotryptamine and [3H]8-Hydroxy-2-(di-n-propylamino) tetraline: analysis in brain of 5-ht1a knockout and 5-ht1a\/1B double-knockout mice","volume":"302","author":"Bonaventure","year":"2002","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2024.110057_bib13","first-page":"1","article-title":"Fmr1 - KO mice failure to detect object novelty associates with a post - test decrease of structural and synaptic plasticity upstream of the hippocampus","author":"Borreca","year":"2023","journal-title":"Sci. Rep."},{"issue":"October","key":"10.1016\/j.neuropharm.2024.110057_bib14","first-page":"1","article-title":"Prevalence of autism spectrum disorder and Co-morbidities in children and adolescents : a systematic literature review","volume":"12","author":"Bougeard","year":"2021"},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110057_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2040-2392-1-15","article-title":"Haploinsufficiency of the autism-associated Shank3 gene leads to deficits in synaptic function, social interaction, and social communication","volume":"1","author":"Bozdagi","year":"2010","journal-title":"Mol. Autism."},{"key":"10.1016\/j.neuropharm.2024.110057_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2021.657774","article-title":"An explanation for repetitive motor behaviors in autism: facilitating inventions via trial-and-error discovery","volume":"12","author":"Caldwell-Harris","year":"2021","journal-title":"Front. Psychiatr."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110057_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40001-022-00838-1","article-title":"Autism-like behaviors regulated by the serotonin receptor 5-HT2B in the dorsal fan-shaped body neurons of Drosophila melanogaster","volume":"27","author":"Cao","year":"2022","journal-title":"Eur. J. Med. Res."},{"issue":"JUL","key":"10.1016\/j.neuropharm.2024.110057_bib18","first-page":"1","article-title":"GABAergic signaling as therapeutic target for autism spectrum disorders","volume":"2","author":"Cellot","year":"2014","journal-title":"Front. Pediatr."},{"issue":"January","key":"10.1016\/j.neuropharm.2024.110057_bib19","article-title":"Gender-specific effect of 5-HT and 5-HIAA on threshold level of behavioral symptoms and sex-bias in prevalence of autism spectrum disorder selection of study participants","volume":"13","author":"Chakraborti","year":"2020"},{"key":"10.1016\/j.neuropharm.2024.110057_bib20","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3389\/fnmol.2019.00141","article-title":"Hyperpolarization-activated cyclic nucleotide-gated channels: an emerging role in neurodegenerative diseases","volume":"12","author":"Chang","year":"2019","journal-title":"Front. Mol. Neurosci."},{"issue":"6","key":"10.1016\/j.neuropharm.2024.110057_bib21","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/jdn.10123","article-title":"Potassium channels and autism spectrum disorder: an overview","volume":"81","author":"Cheng","year":"2021","journal-title":"Int. J. Dev. Neurosci."},{"key":"10.1016\/j.neuropharm.2024.110057_bib22","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.expneurol.2017.04.017","article-title":"The valproic acid-induced rodent model of autism","volume":"299","author":"Chiara Nicolini","year":"2018","journal-title":"Exp. Neurol."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110057_bib23","doi-asserted-by":"crossref","DOI":"10.1038\/srep36250","article-title":"The transgenerational inheritance of autism-like phenotypes in mice exposed to valproic acid during pregnancy","volume":"6","author":"Choi","year":"2016","journal-title":"Sci. Rep."},{"issue":"16","key":"10.1016\/j.neuropharm.2024.110057_bib24","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1001\/jama.2013.2270","article-title":"Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism","volume":"309","author":"Christensen","year":"2013","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.neuropharm.2024.110057_bib25","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2174\/157015906776359540","article-title":"Serotonin as a modulator of glutamate- and GABA-mediated neurotransmission: implications in physiological functions and in pathology","volume":"4","author":"Ciranna","year":"2006","journal-title":"Curr. Neuropharmacol."},{"issue":"August","key":"10.1016\/j.neuropharm.2024.110057_bib26","first-page":"250","article-title":"5-HT7 receptors as modulators of neuronal excitability, synaptic transmission and plasticity: physiological role and possible implications in autism spectrum disorders","volume":"8","author":"Ciranna","year":"2014","journal-title":"Front. Cell. Neurosci."},{"issue":"29","key":"10.1016\/j.neuropharm.2024.110057_bib27","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.biopsych.2012.06.008","article-title":"Activation of 5-HT7 serotonin receptors reverses metabotropic glutamate receptor-mediated synaptic plasticity in wild-type and Fmr1 knockout mice, a model of fragile X syndrome","volume":"72","author":"Costa","year":"2012","journal-title":"Biol. Psychiatr."},{"issue":"March","key":"10.1016\/j.neuropharm.2024.110057_bib28","first-page":"65","article-title":"Novel agonists for serotonin 5-HT7 receptors reverse metabotropic glutamate receptor-mediated long-term depression in the hippocampus of wild-type and Fmr1 KO mice, a model of Fragile X Syndrome","volume":"9","author":"Costa","year":"2015","journal-title":"Front. Behav. Neurosci."},{"issue":"October","key":"10.1016\/j.neuropharm.2024.110057_bib29","first-page":"1","article-title":"Activation of serotonin 5-HT7 receptors modulates hippocampal synaptic plasticity by stimulation of adenylate cyclases and rescues learning and behavior in a mouse model of fragile X syndrome","volume":"11","author":"Costa","year":"2018","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.neuropharm.2024.110057_bib30","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1111\/ejn.15246","article-title":"Serotonin 5- HT7 receptors require cyclin- dependent kinase 5 to rescue hippocampal synaptic plasticity in a mouse model of Fragile X Syndrome","volume":"54","author":"Costa","year":"2021","journal-title":"Eur. J. Neurosci."},{"issue":"3","key":"10.1016\/j.neuropharm.2024.110057_bib31","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/sj.mp.4001409","article-title":"Variants of the serotonin transporter gene (SLC6A4) significantly contribute to hyperserotonemia in autism","volume":"9","author":"Coutinho","year":"2004","journal-title":"Mol. Psychiatr."},{"issue":"October","key":"10.1016\/j.neuropharm.2024.110057_bib32","first-page":"1","article-title":"Neonatal oxytocin treatment ameliorates autistic-like behaviors and oxytocin deficiency in valproic acid-induced rat model of autism","volume":"12","author":"Dai","year":"2018"},{"issue":"11","key":"10.1016\/j.neuropharm.2024.110057_bib33","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1038\/npp.2014.105","article-title":"Pharmacological stimulation of the brain serotonin receptor 7 as a novel therapeutic approach for rett syndrome","volume":"39","author":"De Filippis","year":"2014","journal-title":"Neuropsychopharmacology"},{"issue":"5\u20136","key":"10.1016\/j.neuropharm.2024.110057_bib34","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1159\/000492113","article-title":"Neuroimmune alterations in autism: a translational analysis focusing on the animal model of autism induced by prenatal exposure to valproic acid","volume":"25","author":"Deckmann","year":"2018","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.neuropharm.2024.110057_bib35","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.brainres.2013.06.024","article-title":"Increased hippocampal cell density and enhanced spatial memory in the valproic acid rat model of autism","volume":"1526","author":"Edalatmanesh","year":"2013","journal-title":"Brain Res."},{"issue":"February","key":"10.1016\/j.neuropharm.2024.110057_bib36","first-page":"1","article-title":"Canagliflozin alleviates valproic acid-induced autism in rat pups: role of PTEN\/PDK\/PPAR-\u03b3 signaling pathways","volume":"14","author":"Elgamal","year":"2023","journal-title":"Front. Pharmacol."},{"issue":"January","key":"10.1016\/j.neuropharm.2024.110057_bib37","first-page":"1","article-title":"The 5-HT7 receptor as a potential target for treating drug and alcohol abuse","volume":"8","author":"Engleman","year":"2015"},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110057_bib38","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0166-4328(88)90157-X","article-title":"A new one-trial test for neurobiological studies of memory in rats. 1: behavioral data","volume":"31","author":"Ennaceur","year":"1988","journal-title":"Behav. Brain Res."},{"issue":"6","key":"10.1016\/j.neuropharm.2024.110057_bib39","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/j.neuropharm.2012.06.061","article-title":"5-HT1A and 5-HT7 receptor crosstalk in the regulation of emotional memory: implications for effects of selective serotonin reuptake inhibitors","volume":"63","author":"Eriksson","year":"2012","journal-title":"Neuropharmacology"},{"issue":"July","key":"10.1016\/j.neuropharm.2024.110057_bib40","first-page":"1","article-title":"General developmental health in the VPA-rat model of autism","volume":"7","author":"Favre","year":"2013","journal-title":"Behav. Neurosci."},{"issue":"April","key":"10.1016\/j.neuropharm.2024.110057_bib41","first-page":"1","article-title":"Long-lasting beneficial effects of central serotonin receptor 7 stimulation in female mice modeling Rett syndrome","volume":"9","author":"Filippis","year":"2015"},{"key":"10.1016\/j.neuropharm.2024.110057_bib42","series-title":"Global Prevalence of Autism : A Systematic Review Update Search Strategy","first-page":"778","author":"Fombonne","year":"2022"},{"issue":"3","key":"10.1016\/j.neuropharm.2024.110057_bib43","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.3390\/ijms24032070","article-title":"Therapeutic potential and limitation of serotonin type 7 receptor modulation","volume":"24","author":"Fukuyama","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.neuropharm.2024.110057_bib44","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1113\/jphysiol.2005.086835","article-title":"Kv7\/KCNQ\/M and HCN\/h, but not KCa2\/SK channels, contribute to the somatic medium after-hyperpolarization and excitability control in CA1 hippocampal pyramidal cells","volume":"566","author":"Gu","year":"2005","journal-title":"J. Physiol."},{"issue":"4","key":"10.1016\/j.neuropharm.2024.110057_bib45","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/j.1476-5381.1996.tb15241.x","article-title":"A receptor autoradiographic and in situ hybridization analysis of the distribution of the 5-ht7 receptor in rat brain","volume":"117","author":"Gustafson","year":"1996","journal-title":"Br. J. Pharmacol."},{"issue":"November 2018","key":"10.1016\/j.neuropharm.2024.110057_bib46","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.brainres.2018.12.011","article-title":"Hyperexcitability of hippocampal CA1 pyramidal neurons in male offspring of a rat model of autism spectrum disorder (ASD) induced by prenatal exposure to valproic acid: a possible involvement of Ih channel current","volume":"1708","author":"Hajisoltani","year":"2019","journal-title":"Brain Res."},{"issue":"5","key":"10.1016\/j.neuropharm.2024.110057_bib47","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1001\/archpsyc.1977.01770170031002","article-title":"Hyperserotonemia and amine metabolites in autistic and retarded children","volume":"34","author":"Hanley","year":"1977","journal-title":"Arch. Gen. Psychiatr."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110057_bib48","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.bbr.2008.03.020","article-title":"Molecular biology of 5-HT receptors","volume":"195","author":"Hannon","year":"2008","journal-title":"Behav. Brain Res."},{"issue":"3","key":"10.1016\/j.neuropharm.2024.110057_bib49","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s00213-009-1626-0","article-title":"The 5-HT7 receptor and disorders of the nervous system: an overview","volume":"206","author":"Hedlund","year":"2009","journal-title":"Psychopharmacology (Berlin)"},{"issue":"8","key":"10.1016\/j.neuropharm.2024.110057_bib50","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1038\/s12276-023-01052-7","article-title":"Impact of the circadian nuclear receptor REV-ERB\u03b1 in dorsal raphe 5-HT neurons on social interaction behavior, especially social preference","volume":"55","author":"Jang","year":"2023","journal-title":"Exp. Mol. Med."},{"issue":"5","key":"10.1016\/j.neuropharm.2024.110057_bib51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3892\/mmr.2022.12670","article-title":"The GABAB receptor agonist STX209 reverses the autism-like behaviour in an animal model of autism induced by prenatal exposure to valproic acid","volume":"25","author":"Jiang","year":"2022","journal-title":"Mol. Med. Rep."},{"issue":"Suppl. 3","key":"10.1016\/j.neuropharm.2024.110057_bib52","doi-asserted-by":"crossref","first-page":"S194","DOI":"10.1542\/peds.2016-1159F","article-title":"Autism spectrum disorder in fragile X syndrome: cooccurring conditions and current treatment","volume":"139","author":"Kaufmann","year":"2017","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110057_bib53","doi-asserted-by":"crossref","first-page":"8.8.1","DOI":"10.1002\/0471142301.ns0808s04","article-title":"Measurement of rodent stereotyped behavior","volume":"4","author":"Kelley","year":"1998","journal-title":"Curr. Protoc. Neurosci."},{"issue":"December 2020","key":"10.1016\/j.neuropharm.2024.110057_bib54","article-title":"5-HT7 receptor activation rescues impaired synaptic plasticity in an autistic-like rat model induced by prenatal VPA exposure","volume":"183","author":"Khodaverdi","year":"2021","journal-title":"Neurobiol. Learn. Mem."},{"key":"10.1016\/j.neuropharm.2024.110057_bib55","series-title":"Photobiomodulation Attenuated Cognitive Dysfunction and Neuroinflammation in a Prenatal Valproic Acid-Induced Autism Spectrum Disorder Mouse Model","author":"Kim","year":"2022"},{"issue":"8","key":"10.1016\/j.neuropharm.2024.110057_bib56","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0104927","article-title":"Subchronic treatment of donepezil rescues impaired social, hyperactive, and stereotypic behavior in valproic acid-induced animal model of autism","volume":"9","author":"Kim","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2024.110057_bib57","doi-asserted-by":"crossref","first-page":"407","DOI":"10.4088\/JCP.v67n0311","article-title":"Selective serotonin reuptake inhibitors in autism: a review of efficacy and tolerability","volume":"67","author":"Kolevzon","year":"2006","journal-title":"J. Clin. Psychiatry"},{"issue":"2","key":"10.1016\/j.neuropharm.2024.110057_bib58","first-page":"301","article-title":"Impaired effect of activation of rat hippocampal 5-HT7 receptors, induced by treatment with the 5-HT7 receptor antagonist SB 269970","volume":"66","author":"Kusek","year":"2015","journal-title":"J. Physiol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2024.110057_bib59","doi-asserted-by":"crossref","first-page":"9114","DOI":"10.1021\/acs.jmedchem.7b00965","article-title":"Targets for drug therapy for autism spectrum disorder: challenges and future directions","volume":"60","author":"Lacivita","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.neuropharm.2024.110057_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112395","article-title":"Privileged scaffold-based design to identify a novel drug-like 5-HT 7 receptor-preferring agonist to target Fragile X syndrome","volume":"199","author":"Lacivita","year":"2020","journal-title":"Eur. J. Med. Chem."},{"issue":"2","key":"10.1016\/j.neuropharm.2024.110057_bib61","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0165-3806(02)00550-3","article-title":"Serotonin regulates hippocampal glucocorticoid receptor expression via a 5-HT7 receptor","volume":"139","author":"Laplante","year":"2002","journal-title":"Dev. Brain Res."},{"key":"10.1016\/j.neuropharm.2024.110057_bib62","doi-asserted-by":"crossref","first-page":"6515","DOI":"10.3390\/ijms23126515","article-title":"Serotonin receptors as therapeutic targets for autism spectrum disorder treatment","volume":"23","author":"Lee","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.neuropharm.2024.110057_bib63","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.neuron.2011.09.033","article-title":"Bidirectional regulation of dendritic voltage-gated potassium channels by the fragile X mental retardation protein","volume":"72","author":"Lee","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2024.110057_bib64","series-title":"Modulation of Serotonin Receptors in Neurodevelopmental Disorders : Focus on 5-HT7 Receptor","author":"Lee","year":"2021"},{"issue":"9","key":"10.1016\/j.neuropharm.2024.110057_bib65","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1001\/jamapediatrics.2022.1846","article-title":"Prevalence of autism spectrum disorder among children and adolescents in the United States from 2019 to 2020","volume":"176","author":"Li","year":"2022","journal-title":"JAMA Pediatr."},{"key":"10.1016\/j.neuropharm.2024.110057_bib66","doi-asserted-by":"crossref","first-page":"E3559","DOI":"10.1073\/pnas.1717082115","article-title":"Kv4.2 autism and epilepsy mutation enhances inactivation of closed channels but impairs access to inactivated state after opening","volume":"115","author":"Lin","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"9","key":"10.1016\/j.neuropharm.2024.110057_bib67","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1016\/j.neuron.2022.01.028","article-title":"A direct lateral entorhinal cortex to hippocampal CA2 circuit conveys social information required for social memory","volume":"110","author":"Lopez-Rojas","year":"2022","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2024.110057_bib68","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2014.00027","article-title":"Deletion of PTEN produces autism-like behavioral deficits and alterations in synaptic proteins","volume":"7","author":"Lugo","year":"2014","journal-title":"Front. Mol. Neurosci."},{"issue":"11","key":"10.1016\/j.neuropharm.2024.110057_bib69","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1002\/aur.2597","article-title":"Vinpocetine amended prenatal valproic acid induced features of ASD possibly by altering markers of neuronal function, inflammation, and oxidative stress","volume":"14","author":"Luhach","year":"2021","journal-title":"Autism Res."},{"issue":"19","key":"10.1016\/j.neuropharm.2024.110057_bib70","doi-asserted-by":"crossref","first-page":"7613 LP","DOI":"10.1523\/JNEUROSCI.18-19-07613.1998","article-title":"Dendritic hyperpolarization-activated currents modify the integrative properties of hippocampal CA1 pyramidal neurons","volume":"18","author":"Magee","year":"1998","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2024.110057_bib71","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.ajhg.2007.12.009","article-title":"Structural variation of chromosomes in autism spectrum disorder","volume":"82","author":"Marshall","year":"2008","journal-title":"Am. J. Hum. Genet."},{"issue":"2","key":"10.1016\/j.neuropharm.2024.110057_bib72","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1601-183X.2007.00330.x","article-title":"Autism-like behavioral phenotypes in BTBR T+tf\/J mice","volume":"7","author":"McFarlane","year":"2008","journal-title":"Gene Brain Behav."},{"issue":"9","key":"10.1016\/j.neuropharm.2024.110057_bib73","first-page":"1","article-title":"CA1 pyramidal cells have diverse biophysical properties, affected by development, experience, and aging","volume":"2017","author":"Mckiernan","year":"2017","journal-title":"PeerJ"},{"key":"10.1016\/j.neuropharm.2024.110057_bib74","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.neuroscience.2015.11.010","article-title":"The serotonin system in autism spectrum disorder: from biomarker to animal models","volume":"321","author":"Muller","year":"2016","journal-title":"Neuroscience"},{"issue":"December","key":"10.1016\/j.neuropharm.2024.110057_bib75","article-title":"Asymmetry in the central nervous system: a clinical neuroscience perspective","volume":"15","author":"Mundorf","year":"2021","journal-title":"Front. Syst. Neurosci."},{"issue":"3","key":"10.1016\/j.neuropharm.2024.110057_bib76","first-page":"265","article-title":"Stimulation of the serotonin receptor 7 restores brain histone H3 acetylation and MeCP2 corepressor protein levels in a female mouse model of rett syndrome","volume":"80","author":"Napoletani","year":"2021"},{"issue":"5","key":"10.1016\/j.neuropharm.2024.110057_bib77","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1021\/cr078224o","article-title":"Serotonin receptors","volume":"108","author":"Nichols","year":"2008","journal-title":"Chem. Rev."},{"issue":"6","key":"10.1016\/j.neuropharm.2024.110057_bib78","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0066695","article-title":"Effects of the selective 5-HT7 receptor antagonist SB-269970 and amisulpride on ketamine-induced schizophrenia-like deficits in rats","volume":"8","author":"Nikiforuk","year":"2013","journal-title":"PLoS One"},{"issue":"MAY 2012","key":"10.1016\/j.neuropharm.2024.110057_bib79","first-page":"1","article-title":"The hippocampus supports multiple cognitive processes through relational binding and comparison","volume":"6","author":"Olsen","year":"2012","journal-title":"Front. Hum. Neurosci."},{"key":"10.1016\/j.neuropharm.2024.110057_bib80","article-title":"Strain differences in behaviour and immunity in aged mice: relevance to Autism","volume":"399","author":"O'Connor","year":"2021","journal-title":"Behav. Brain Res."},{"issue":"8","key":"10.1016\/j.neuropharm.2024.110057_bib81","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/nn891","article-title":"Pharmacological upregulation of h-channels reduces the excitability of pyramidal neuron dendrites","volume":"5","author":"Poolos","year":"2002","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2024.110057_bib82","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.bbr.2014.04.045","article-title":"Ameliorating effect of piperine on behavioral abnormalities and oxidative markers in sodium valproate induced autism in BALB\/C mice","volume":"270","author":"Pragnya","year":"2014","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2024.110057_bib83","series-title":"Robinson-Agramonte M de los A","first-page":"13","article-title":"Epidemiology of autism spectrum disorders BT - translational approaches to autism spectrum disorder","author":"Presmanes Hill","year":"2015"},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110057_bib84","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0014-2999(03)01272-X","article-title":"The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review","volume":"463","author":"Prut","year":"2003","journal-title":"Eur. J. Pharmacol."},{"issue":"June","key":"10.1016\/j.neuropharm.2024.110057_bib85","article-title":"Alterations in the intrinsic discharge activity of CA1 pyramidal neurons associated with possible changes in the NADPH diaphorase activity in a rat model of autism induced by prenatal exposure to valproic acid","volume":"1792","author":"Rahdar","year":"2022","journal-title":"Brain Res."},{"issue":"8","key":"10.1016\/j.neuropharm.2024.110057_bib86","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1017\/S0012162205001076","article-title":"Characteristics of fetal anticonvulsant syndrome associated autistic disorder","volume":"47","author":"Rasalam","year":"2005","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.neuropharm.2024.110057_bib87","doi-asserted-by":"crossref","DOI":"10.1016\/j.nicl.2020.102207","article-title":"Increased hippocampal shape asymmetry and volumetric ventricular asymmetry in autism spectrum disorder","volume":"26","author":"Richards","year":"2020","journal-title":"Neuroimage Clin."},{"issue":"4","key":"10.1016\/j.neuropharm.2024.110057_bib88","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/hipo.20938","article-title":"The 5-HT(7) receptor in learning and memory","volume":"22","author":"Roberts","year":"2012","journal-title":"Hippocampus"},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110057_bib89","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1146\/annurev.physiol.65.092101.142734","article-title":"Hyperpolarization-activated cation currents: from molecules to physiological function","volume":"65","author":"Robinson","year":"2003","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.neuropharm.2024.110057_bib90","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1134\/S1819712421010098","article-title":"Serotonin 5-ht1a, 5-ht2a, and 5-HT7 receptors in the brain of the BTBR mouse the model of autism","volume":"15","author":"Rodnyy","year":"2021","journal-title":"Neurochem. J."},{"key":"10.1016\/j.neuropharm.2024.110057_bib91","first-page":"1","article-title":"The brain serotonin system in autism","author":"Rodnyy","year":"2023","journal-title":"Rev. Neurosci."},{"issue":"SEP","key":"10.1016\/j.neuropharm.2024.110057_bib92","first-page":"1","article-title":"The role of the hippocampus in flexible cognition and social behavior","volume":"8","author":"Rubin","year":"2014","journal-title":"Front. Hum. Neurosci."},{"issue":"10","key":"10.1016\/j.neuropharm.2024.110057_bib93","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.tins.2003.08.003","article-title":"The multiple personalities of h-channels","volume":"26","author":"Santoro","year":"2003","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2024.110057_bib94","series-title":"Autism","first-page":"35","article-title":"Chapter Two - role of environmental factors and epigenetics in autism spectrum disorders","author":"Saxena","year":"2020"},{"issue":"3","key":"10.1016\/j.neuropharm.2024.110057_bib95","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0022-3476(61)80261-8","article-title":"Studies on 5-bydroxyindole metabolism in autistic and other mentally retarded children","volume":"58","author":"Schain","year":"1961","journal-title":"J. Pediatr."},{"issue":"62","key":"10.1016\/j.neuropharm.2024.110057_bib96","article-title":"Targeting PPAR\u03b1 in the rat valproic acid model of autism: focus on social motivational impairment and sex-related differences","volume":"11","author":"Scheggi","year":"2020","journal-title":"Mol. Autism."},{"key":"10.1016\/j.neuropharm.2024.110057_bib97","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.neuroscience.2022.06.016","article-title":"Participation of hippocampal 5-HT(5A), 5-HT(6) and 5-HT(7) serotonin receptors on the consolidation of social recognition memory","volume":"497","author":"Schmidt","year":"2022","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2024.110057_bib98","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/BF02802024","article-title":"Tengis Gloveli Rme UH.& Comparison of the effects of serotonin in the hippocampus and the entorhinal cortex","volume":"17","author":"Schmitz","year":"1998","journal-title":"Mol. Neurobiol."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110057_bib99","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/sj.npp.1300518","article-title":"Behavioral alterations in rats prenatally exposed to valproic acid: animal model of autism","volume":"30","author":"Schneider","year":"2005","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110057_bib100","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0006-8993(75)90881-1","article-title":"Physiological and pharmacological evidence for a serotonergic projection to the hippocampus","volume":"94","author":"Segal","year":"1975","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2024.110057_bib101","first-page":"1","article-title":"Juvenile handling rescues autism - related effects of prenatal exposure to valproic acid","author":"Seiffe","year":"2022","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.neuropharm.2024.110057_bib102","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.tins.2010.03.002","article-title":"Dendritic ion channel trafficking and plasticity","volume":"33","author":"Shah","year":"2010","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2024.110057_bib103","series-title":"Evaluating the Effect of R-Baclofen and LP-211 on Autistic Behavior of the BTBR and Fmr1 -KO Mouse Models","first-page":"1","author":"Sharghi","year":"2023"},{"issue":"45","key":"10.1016\/j.neuropharm.2024.110057_bib104","doi-asserted-by":"crossref","first-page":"33168","DOI":"10.1074\/jbc.M703736200","article-title":"Activity-dependent regulation of h channel distribution in hippocampal CA1 pyramidal neurons","volume":"282","author":"Shin","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"November","key":"10.1016\/j.neuropharm.2024.110057_bib105","first-page":"1","article-title":"Social factors influence behavior in the novel object recognition task in a mouse model of down syndrome","volume":"15","author":"Sierra","year":"2021","journal-title":"Front. Behav. Neurosci."},{"issue":"June","key":"10.1016\/j.neuropharm.2024.110057_bib106","article-title":"5-HT7 receptors increase the excitability of hippocampal CA1 pyramidal neurons by inhibiting the A-type potassium current","volume":"177","author":"Siwiec","year":"2020","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110057_bib107","article-title":"Activation of 5-HT7 receptors affects neuronal excitability in rat CA1 hippocampus by inhibiting fast inactivating potassium channels","volume":"77","author":"Sowa","year":"2017","journal-title":"Acta Neurobiol. Exp."},{"key":"10.1016\/j.neuropharm.2024.110057_bib108","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3389\/fnbeh.2018.00025","article-title":"Impaired object recognition but normal social behavior and ultrasonic communication in Cofilin1 mutant mice","volume":"12","author":"Sungur","year":"2018","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.neuropharm.2024.110057_bib109","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111322","article-title":"Emerging mechanisms of valproic acid-induced neurotoxic events in autism and its implications for pharmacological treatment","volume":"137","author":"Taleb","year":"2021","journal-title":"Biomed. Pharmacother."},{"issue":"4","key":"10.1016\/j.neuropharm.2024.110057_bib110","doi-asserted-by":"crossref","first-page":"329","DOI":"10.29090\/psa.2020.04.019.0042","article-title":"Amelioration of motor behavioral aberrations and cerebellar abnormalities by ethanol leaf extract of balakat tree (ziziphus talanai (blanco) merr.) in valproic acid mice model of autism","volume":"47","author":"Tejano","year":"2020","journal-title":"Pharm. Sci. Asia"},{"issue":"1\u20132","key":"10.1016\/j.neuropharm.2024.110057_bib111","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.brainres.2003.09.015","article-title":"5-HT7 receptors increase the excitability of rat hippocampal CA1 pyramidal neurons","volume":"993","author":"Tokarski","year":"2003","journal-title":"Brain Res."},{"issue":"5","key":"10.1016\/j.neuropharm.2024.110057_bib112","first-page":"535","article-title":"5-HT 7 receptors modulate gabaergic transmission in rat hippocampal CA1 area","volume":"62","author":"Tokarski","year":"2011","journal-title":"J. Physiol. Pharmacol."},{"issue":"6","key":"10.1016\/j.neuropharm.2024.110057_bib113","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.neuron.2007.11.015","article-title":"HCN1 channels constrain synaptically evoked Ca2+ spikes in distal dendrites of CA1 pyramidal neurons","volume":"56","author":"Tsay","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2024.110057_bib114","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.neuropharm.2017.04.024","article-title":"Stimulation of the brain serotonin receptor 7 rescues mitochondrial dysfunction in female mice from two models of Rett syndrome","volume":"121","author":"Valenti","year":"2017","journal-title":"Neuropharmacology"},{"issue":"7","key":"10.1016\/j.neuropharm.2024.110057_bib115","doi-asserted-by":"crossref","first-page":"8110","DOI":"10.1096\/fj.201802488R","article-title":"Natural disease history of the D2-mdx mouse model for Duchenne muscular dystrophy","volume":"33","author":"van Putten","year":"2019","journal-title":"Faseb. J."},{"issue":"6","key":"10.1016\/j.neuropharm.2024.110057_bib116","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.180265","article-title":"Understanding intellectual disability and utism spectrum disorders from common mouse models: synapses to behaviour","volume":"9","author":"Verma","year":"2019","journal-title":"Open Biol."},{"key":"10.1016\/j.neuropharm.2024.110057_bib117","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.jocn.2020.03.049","article-title":"Abnormal development pattern of the amygdala and hippocampus from childhood to adulthood with autism","volume":"78","author":"Xu","year":"2020","journal-title":"J. Clin. Neurosci."},{"issue":"1\u20133","key":"10.1016\/j.neuropharm.2024.110057_bib118","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ejphar.2012.04.011","article-title":"Involvement of 5-HT\u2087 receptors in the pathogenesis of temporal lobe epilepsy","volume":"685","author":"Yang","year":"2012","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2024.110057_bib120","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.neuro.2023.05.009","article-title":"Social deficits in mice prenatally exposed to valproic acid are intergenerationally inherited and rescued by social enrichment","volume":"97","author":"Zappala","year":"2023","journal-title":"Neurotoxicology"},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110057_bib121","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/s41398-019-0608-1","article-title":"Maternal valproic acid exposure leads to neurogenesis defects and autism-like behaviors in non-human primates","volume":"9","author":"Zhao","year":"2019","journal-title":"Transl. Psychiatry"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390824002260?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390824002260?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T10:51:29Z","timestamp":1728298289000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390824002260"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":120,"alternative-id":["S0028390824002260"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2024.110057","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reversal of electrophysiological and behavioral deficits mediated by 5-HT7 receptor upregulation following LP-211 treatment in an autistic-like rat model induced by prenatal valproic acid exposure","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2024.110057","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110057"}}